Kolexia
Gauthier Mélanie
Pharmacien
Hôpital Brabois
Vandoeuvre-lès-Nancy, France
20 Activités
47 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Inflammation Lésion pulmonaire aigüe Syndrome de détresse respiratoire de l'adulte Syndrome de détresse respiratoire du nouveau-né Tumeurs du sein Tumeurs de la prostate Syndrome respiratoire aigu sévère Maladies virales

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
HemaSphere   27 janvier 2024
Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital.
Bulletin du cancer   05 septembre 2023
Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial.
Frontiers in medicine   29 août 2023
Scale-Up of Academic Mesenchymal Stromal Cell Production.
Journal of clinical medicine   30 juin 2023
A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Cytotherapy   17 avril 2023
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input.
Cancers   04 février 2023
MSC-COVID19: Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial
Essai Clinique (CHU Nancy)   28 octobre 2021
Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells.
Critical reviews in oncology/hematology   16 février 2021
Adoptive Immunotherapy of Refractory Viral Infections after Allogeneic HSCT: An Academic Network Framing the use of an Atmp under Hospital Exemption
Abstracts from the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)   01 décembre 2020
Mesenchymal Stem/stromal Cell Production Compliant with Good Manufacturing Practice: Comparison Between Bone Marrow and Wharton’s Jelly
Abstracts from the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)   01 décembre 2020